Announcements Trials
Browse Landscape

Phase

Phase 2 58Phase 1 44Phase NA 43Phase 1/2 34Phase 3 16Phase EARLY_PHASE1 5Phase 4 4Phase 2/3 1

Status

Completed 17Recruiting 5Active not recruiting 3Withdrawn 2Terminated 2Unknown 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5CNS 1

Conditions

Multiple Myeloma 27Breast Neoplasms 23Neoplasms 22Pancreatic Neoplasms 19Prostatic Neoplasms 17Glioma 17Glioblastoma 16Leukemia, Myeloid, Acute 15Recurrence 14Solid Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma 8Hematologic Neoplasms 8Melanoma 7Lymphoma, B-Cell 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Advanced Solid Tumors 7Polycystic Ovary Syndrome 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Myelodysplastic Syndromes 5Leukemia, Plasma Cell 5

Interventions

lenvatinib 2pembrolizumab 1cabozantinib 1Nivolumab 1Ipilimumab 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recruiting × Carcinoma, Renal Cell × Clear all
NCT03810651 2026-04-15

Pencil Beam Scanning in Patients With Renal Tumors

Children's Hospital of Philadelphia

Phase EARLY_PHASE1 Recruiting
28 enrolled
Genitourinary

Carcinoma, Renal Cell, Wilms Tumor

NCT05733715 2026-03-24

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Recruiting
30 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07067905 2025-07-16

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

Chinese PLA General Hospital

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNSGenitourinary

Carcinoma, Renal Cell, Glioblastoma

NCT05188118 2024-11-06

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

Icahn School of Medicine at Mount Sinai

Phase EARLY_PHASE1 Recruiting
20 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT06586658 2024-10-22

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Recruiting
9 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡